ONC
BeOne Medicines Ltd
259 hedge funds and large institutions have $15B invested in BeOne Medicines Ltd in 2021 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 82 increasing their positions, 90 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less ownership
Funds ownership: →
9% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 90
26% less capital invested
Capital invested by funds: $20.4B → $15B (-$5.35B)
77% less call options, than puts
Call options by funds: $28.3M | Put options by funds: $125M
Holders
259
Holding in Top 10
12
Calls
$28.3M
Puts
$125M
Top Buyers
| 1 | +$24.4M | |
| 2 | +$14.5M | |
| 3 | +$14.4M | |
| 4 |
SCM
Segantii Capital Management
Hong Kong
|
+$12.3M |
| 5 |
BCP
BSN Capital Partners
London,
United Kingdom
|
+$11.8M |
Top Sellers
| 1 | -$71.6M | |
| 2 | -$50.6M | |
| 3 | -$48.1M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$36M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$33.9M |